Position in BMRN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$467,830
+$5,968 QoQ
Shares Held
8,176
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 39 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOODSTOCK CORP holds $23,238,186 across 10 Biotechnology names. BMRN ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,518 | $12,793,793 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
18,345 | $5,798,671 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,005 | $1,989,403 | |
| 4 | EYPT |
EyePoint, Inc.
|
68,465 | $979,049 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
242,756 | $517,070 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
8,176 | $467,830 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
9,191 | $306,887 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
|
20,609 | $259,261 |
All Filings in BMRN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $467,830 | 8,176 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $461,862 | 8,176 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $485,899 | 8,176 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $442,812 | 8,176 | Shares | Sole | 2025-10-07 | |
| No filing history on record for this holder in this stock. | ||||||